Colgate-Palmolive and Clorox are both staples of the consumer household-products sector, yet they occupy different corners of it. CL is anchored in oral care and pet nutrition with a deep global footprint, while CLX is concentrated in cleaning, home-care, and lifestyle brands with heavier U.S. exposure. For income-oriented investors, the two offer sharply different dividend profiles; for growth-focused traders, their momentum and margin trajectories have diverged in recent weeks. This stock comparison examines relative performance, business-model contrasts, and market positioning to help readers understand which name currently offers the more compelling risk-and-reward setup.
CL, Colgate-Palmolive, generates revenue from oral care, personal and home care, and its fast-growing Hill's Pet Nutrition division. Recent quarters have shown a familiar pattern: solid emerging-market momentum offsetting softer U.S. demand. In its most recent quarter, revenue rose by a mid-single-digit percentage, supported by strength in India, Brazil, Mexico, and China, while North America posted an organic sales decline. Gross margin expanded as pricing, mix, and productivity absorbed higher advertising investment. The board also raised the quarterly dividend, underscoring cash-flow reliability. Sentiment has been broadly constructive, though the stock's premium valuation, near 22–23 times forward earnings, leaves less room for execution missteps. Its very low beta (a measure of price sensitivity to the broader market) reinforces its defensive, low-volatility character.
CLX, Clorox, owns brands including Clorox, Glad, Hidden Valley, Brita, Burt's Bees, Fresh Step, Kingsford, and, following its April 2026 acquisition of GOJO Industries, Purell. Its recent performance has been shaped less by steady demand and more by operational transitions: the completion of a major U.S. ERP rollout and the reversal of prior-year inventory shipments created a temporary drag on sales and earnings comparisons. Clorox also completed the GOJO acquisition, which is expected to add several points of sales growth. Gross margin has contracted on higher manufacturing, logistics, and inflation costs, and the balance sheet is more leveraged. Nevertheless, the stock rebounded strongly in recent weeks as investors digested a better-than-feared quarterly result and a fiscal 2027 outlook that incorporates acquisition-driven top-line growth and eventual margin recovery.
Tickeron maintains a library of hundreds of AI trading bots that collectively trade thousands of different tickers across a wide range of strategies, timeframes, and performance statistics. Because market conditions shift constantly, not every bot is well suited to every environment — which is why only the strongest, most adaptable systems earn a place in the curated Trending AI Robots section. These bots differ in trading style, holding period, risk profile, and the specific sets of tickers they monitor, giving users a way to compare approaches side by side. If you are evaluating names like CL and CLX and want to see how data-driven systems are currently positioning, the Trending AI Robots page offers a practical starting point.
The clearest contrast between these two stocks is diversification versus concentration. CL spreads risk across geographies and categories, with emerging markets and pet nutrition acting as durable growth engines even when U.S. categories soften. CLX is more dependent on U.S. household demand and is still working through a multi-year operational reset, making its near-term results more volatile.
Valuation and income also diverge. CL commands a premium multiple but a modest yield near 2.4%, reflecting its consistency and lower beta. CLX trades at a discount multiple yet yields roughly 5.8%, a level that reflects both its higher leverage and the market's caution around margin recovery. On momentum, CL has shown steadier, more broad-based growth, while CLX's recent strength leans on acquisition and comparison effects rather than broad demand acceleration. In short, CL offers stability at a higher price, while CLX offers income and potential turnaround upside at a higher risk.
Based on observable factors, Tickeron's AI would likely favor CL for its superior trend consistency, more stable earnings trajectory, lower volatility, and diversified growth drivers. CLX's high yield and acquisition-driven rebound are notable, but its weaker earnings-revision trend, compressed margins, and elevated leverage introduce greater uncertainty. A quantitative system weighing trend stability, relative positioning, and risk would probably assign a higher probability of steady performance to CL, while treating CLX as a higher-risk, higher-income alternative better suited to investors with a longer tolerance for volatility and turnaround execution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for CL crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 29 of 59 cases where CL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on CL as a result. In 31 of 68 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 46%.
The Moving Average Convergence Divergence (MACD) for CL just turned positive on October 06, 2026. Looking at past instances where CL's MACD turned positive, the stock continued to rise in 22 of 43 cases over the following month. The odds of a continued upward trend are 51%.
CL moved above its 50-day moving average on October 12, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where CL advanced for three days, in 145 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 118 of 277 cases where CL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 43%.
The 10-day RSI Indicator for CL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In 14 of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at 36%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 47%.
CL broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 29 (best 1 - 100 worst), indicating outstanding price growth. CL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CL's P/B Ratio (329.104) is very high in comparison to the industry average of (20.672). P/E Ratio (38.358) is within average values for comparable stocks, (16.840). Projected Growth (PEG Ratio) (1.577) is also within normal values, averaging (1.518). Dividend Yield (0.022) settles around the average of (0.033) among similar stocks. P/S Ratio (3.331) is also within normal values, averaging (1.902).
CLX broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 32 similar instances where the stock broke above the upper band. In 23 of the 32 cases the stock fell afterwards. This puts the odds of success at 72%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLX's RSI Oscillator exited the oversold zone, 14 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 40%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CLX as a result. In 49 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for CLX just turned positive on October 05, 2026. Looking at past instances where CLX's MACD turned positive, the stock continued to rise in 23 of 47 cases over the following month. The odds of a continued upward trend are 49%.
CLX moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLX advanced for three days, in 180 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 75 of 193 cases where CLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 39%.
The Tickeron Seasonality Score of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. CLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CLX's P/B Ratio (120.797) is slightly higher than the industry average of (20.672). P/E Ratio (18.651) is within average values for comparable stocks, (16.840). Projected Growth (PEG Ratio) (1.019) is also within normal values, averaging (1.518). Dividend Yield (0.056) settles around the average of (0.033) among similar stocks. P/S Ratio (1.542) is also within normal values, averaging (1.902).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
CL | CLX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 42 | 100 | |
SMR RATING 1..100 | 8 | 10 | |
PRICE GROWTH RATING 1..100 | 29 | 50 | |
P/E GROWTH RATING 1..100 | 7 | 39 | |
SEASONALITY SCORE 1..100 | n/a | 4 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CLX's Valuation (96) in the Household Or Personal Care industry is in the same range as CL (99). This means that CLX’s stock grew similarly to CL’s over the last 12 months.
CL's Profit vs Risk Rating (42) in the Household Or Personal Care industry is somewhat better than the same rating for CLX (100). This means that CL’s stock grew somewhat faster than CLX’s over the last 12 months.
CL's SMR Rating (8) in the Household Or Personal Care industry is in the same range as CLX (10). This means that CL’s stock grew similarly to CLX’s over the last 12 months.
CL's Price Growth Rating (29) in the Household Or Personal Care industry is in the same range as CLX (50). This means that CL’s stock grew similarly to CLX’s over the last 12 months.
CL's P/E Growth Rating (7) in the Household Or Personal Care industry is in the same range as CLX (39). This means that CL’s stock grew similarly to CLX’s over the last 12 months.
| CL | CLX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 36% | 1 day ago 40% |
| Stochastic ODDS (%) | 1 day ago 49% | 1 day ago 58% |
| Momentum ODDS (%) | 1 day ago 46% | 1 day ago 51% |
| MACD ODDS (%) | 1 day ago 51% | 1 day ago 49% |
| TrendWeek ODDS (%) | 1 day ago 50% | 1 day ago 51% |
| TrendMonth ODDS (%) | 1 day ago 51% | 1 day ago 45% |
| Advances ODDS (%) | 1 day ago 46% | 5 days ago 56% |
| Declines ODDS (%) | 6 days ago 47% | N/A |
| BollingerBands ODDS (%) | 1 day ago 41% | 1 day ago 72% |
| Aroon ODDS (%) | 1 day ago 43% | 1 day ago 39% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CL’s FA Score shows that 3 FA rating(s) are green while CLX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CL’s TA Score shows that 7 TA indicator(s) are bullish while CLX’s TA Score has 6 bullish TA indicator(s).
CL (@Household/Personal Care) experienced а +4.65% price change this week, while CLX (@Household/Personal Care) price change was +5.12% for the same time period.
The average weekly price growth across all stocks in the @Household/Personal Care industry was -0.77%. For the same industry, the average monthly price growth was +0.60%, and the average quarterly price growth was +7.88%.
CL is expected to report earnings on Jan 22, 2027.
CLX is expected to report earnings on Feb 04, 2027.
Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.